Liquidia (LQDA) Long-Term Debt Issuances (2021 - 2025)
Liquidia (LQDA) recorded quarterly Long-Term Debt Issuances of $50.0 million in Q2 2025, up 100.2% quarter-over-quarter from $25.0 million in Q1 2025.
Liquidia (LQDA) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends
Liquidia's Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $50.0 million for Q2 2025.
- In Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to $50.0 million; the TTM figure through Mar 2026 stood at $50.0 million (down 12.98% YoY), while the FY2025 annual figure was $75.0 million, up 30.48% from the prior year.
- Long-Term Debt Issuances was $50.0 million for Q2 2025 at Liquidia, up from $25.0 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $50.0 million in Q2 2025 to a low of $10.4 million in Q1 2021.
- Historically, Long-Term Debt Issuances has averaged $29.2 million across 5 years, with a median of $25.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Long-Term Debt Issuances surged 89.88% in 2022, then changed 0.0% in 2025.
- A 5-year view of Long-Term Debt Issuances shows it stood at $10.4 million in 2021, then surged by 89.88% to $19.8 million in 2022, then jumped by 111.18% to $41.7 million in 2023, then fell by 22.18% to $32.5 million in 2024, then surged by 53.92% to $50.0 million in 2025.
- The last three Long-Term Debt Issuances figures came in at $50.0 million (Q2 2025), $25.0 million (Q1 2025), and $32.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 24.98 Mn |
| Mar 31, 2025 | 24.98 Mn |
| Sep 30, 2024 | 32.49 Mn |
| Sep 30, 2024 | 32.49 Mn |
| Mar 31, 2024 | 24.98 Mn |
| Mar 31, 2024 | 24.98 Mn |
| Dec 31, 2023 | 41.74 Mn |
| Dec 31, 2023 | 41.74 Mn |
| Mar 31, 2022 | 19.77 Mn |
| Mar 31, 2022 | 19.77 Mn |
| Mar 31, 2021 | 10.41 Mn |
| Mar 31, 2021 | 10.41 Mn |